Publications by authors named "Mark M Whitmore"

Claim this Profile
I
Interleukin-18 (IL-18) engineered for half-life extension and resistance to IL-18 binding protein (IL-18BP) to enhance anti-cancer therapeutic potential.
Kristiana H Dreaden, Su-Ping Pearson, Pinar S Gurel, Robert G Newman, Yanchun Zhao, Mark M Whitmore

Cytokine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative regulation of TLR-signaling pathways by activating transcription factor-3.
Mark M Whitmore, Amaya Iparraguirre, Lindsey Kubelka, Wolfgang Weninger, Tsonwin Hai

J Immunol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enlarged spleens without enlarged lymph nodes in tlr3-/- pkr-/- mice.
Christine L White, Mark M Whitmore, Bryan R G Williams

J Interferon Cytokine Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Mark M Whitmore, Michael J DeVeer, Andrea Edling, Rhonda K Oates, Brenna Simons

Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis